Disposable Reflective Marker Spheres (AM-BK115S, AM-BL130S)
Guangzhou Aimooe Technology Co., Ltd. · Decision date Oct 15, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-15 for K262214, a traditional 510(k) from Guangzhou Aimooe Technology Co., Ltd. for Disposable Reflective Marker Spheres (AM-BK115S, AM-BL130S). The device falls under regulation number 882.4560, classification product code HAW, device classification name Neurological Stereotaxic Instrument, with Neurology as the regulation medical specialty and review panel. The application was received 06/30/2026 and was not reviewed by a third party; it was not recorded as a combination product, and no predetermined change control plan was authorized.
SESE means the submission was cleared as substantially equivalent to a predicate; it is not a PMA approval. The public record does not identify the predicate device, the specific materials or dimensional differences between the two model numbers, or any performance data supporting equivalence, so the technical basis for the clearance remains unknown from this source.
The same decision appears in CDRH's listing of 510(k) final decisions rendered since October 01, 2026, published 15 Oct 2026, matching the device name and applicant.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Oct 15, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262214
- Regulatory pathway
- 510(k) premarket notification
- Product code
- HAW
- Decision code
- SESE
- Decision date
- Oct 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Neurological Stereotaxic Instrument.
- Product code
- HAW
- FDA device class
- 2
FDA decision timeline
K262214 received
Application receipt date recorded by FDA.
K262214 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HAW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| inomed Medizintechnik GmbH | 510(k) clearance | Nov 6, 2026 | FDA | |
| Medtronic Navigation | 510(k) clearance | Nov 6, 2026 | FDA | |
NeuroAlignK261997 | Medivis, Inc. | 510(k) clearance | Oct 26, 2026 | FDA |
| Koh Young Technology, Inc. | 510(k) clearance | Sep 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Guangzhou Aimooe Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Guangzhou
Sources and methodology
- Original FDA record: K262214
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
